Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

This reports provides a data-driven overview of the current and future competitive landscape in Dravet Syndrome therapeutics.

Synopsis

• In 2022, there will be more than 123,000 diagnosed prevalent cases of Dravet syndrome across 16 pharmaceutical markets.
• Two FDA-approved branded marketed drugs are available for the treatment of Dravet syndrome.
• The Dravet syndrome pipeline consists of 38 pharmaceuticals spanning all stages of development, with more than 90% of drugs in early-stage development.
• Commercial sponsors dominate clinical trial development in Dravet syndrome, with the US emerging as the key country for conducting trials in Dravet syndrome.
• Deals involving licensing and partnership for Dravet syndrome assets are the most common types of deals globally.
• Companies are increasingly focusing on R&D activities to develop anti-epileptic drugs (AEDs) with novel mechanisms of action.

Scope

GlobalData's Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action and Route of Administration
• Product Profiles with Sales Forecast
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Late-to-mid-stage Pipeline Drugs
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Dravet Syndrome market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Dravet Syndrome market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.